Hepatic Reduce dose; contraindicated in marked liver impairment
Instructions
Individualize dose by age, weight, condition
Reduce dose in elderly or debilitated patients
Withdraw gradually after prolonged use to avoid withdrawal (delirium, convulsions)
Available strengths
cap 100 mg
Contraindications
History of manifest or latent porphyria
Marked impairment of liver function
Respiratory disease in which dyspnea or obstruction is evident
Cautions
Habit-forming; tolerance, psychological and physical dependence
Abrupt cessation after prolonged use may cause withdrawal (delirium, convulsions, death)
Complex sleep behaviors (sleep-driving)
Caution in acute or chronic pain (paradoxical excitement/masked symptoms)
Additive CNS depression with alcohol/other CNS depressants
Caution in mentally depressed/suicidal/history of drug abuse
Adverse reactions
Somnolence
Agitation
Confusion
Ataxia
Hypoventilation/apnea
Bradycardia
Hypotension
Nausea
Vomiting
Hypersensitivity reactions
Pregnancy Pregnancy Category D — can cause fetal harm; withdrawal in infants exposed in last trimester
Lactation Small amounts excreted in milk; exercise caution in nursing women
Cost
Secobarbital (SECONAL)
Strength
#/mo
generic $/mo
CostPlus
100 mg
cap
30 qd
not offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Secobarbital is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.